Athanor Capital, LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,330,000
+193.0%
55,920
+221.9%
0.03%
+210.0%
Q4 2020$454,000
-35.1%
17,372
-56.7%
0.01%
-63.0%
Q3 2020$699,000
+49.0%
40,136
+43.9%
0.03%
+12.5%
Q2 2020$469,00027,8950.02%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders